Structure |
Chemical Name |
CAS |
MF |
|
(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
58233-18-4 |
C15H16N4O6S2 |
|
4-(dimethylammonio)piperidinium dichloride |
4876-59-9 |
C7H18Cl2N2 |
|
Dolutegravir intermediate |
|
|
|
(7S)-Cefuroxime |
|
|
|
5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride |
4935-81-3 |
C36H28ClN5 |
|
Engelide intermediate |
|
|
|
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate |
154330-68-4 |
C16H15F2NO4S |
|
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
|
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
|
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
|
5-Methyl-4-isoxazolecarboxylic acid |
42831-50-5 |
C5H5NO3 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2 |
363-23-5 |
C20H32O5 |
|
Ceftiofur Double Mother Nucleus |
|
|
|
7S-Cephalexin |
|
|
|
(6R,7S)-Latamoxef MotherNucleus |
|
|
|
COUMARIN 6 |
88241-65-0 |
C15H12O2 |
|
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
|
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
|
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
|
Inosine API manufacturers |
|
|
|
3’-deoxyinosine |
|
|
|
Acetoxy Ceftazidime Intermediate |
|
|
|
Flomoxef Intermediate FXMT |
|
|
|
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
|
Pyrazole |
288-13-1 |
C3H4N2 |
|
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
|
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
|
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
|
(3R,4R,5R)-Oseltamivir |
|
|
|
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
|
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
|
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
|
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
|
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
|
cytidylyl(5'->3')adenosine |
4833-63-0 |
C19H25N8O11P |
|
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
|
1-(benzo[d][1,3]dioxol-5-yl)-2-bromopropan-1-one |
52190-28-0 |
C10H9BrO3 |
|
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
|
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
|
11-Prostaglandin F2a |
|
|
|
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
|
Rimonabant hydrochloride |
158681-13-1 |
C22H21Cl3N4O.ClH |
|
5-bromo-2-chloro-4’-ethoxydiphenylmethane |
461432-23-5 |
C15H14BrClO |
|
3-isobutylglutaric anhydride |
185815-59-2 |
C9H14O3 |
|
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |
|
L-(+)-Ergothioneine |
497-30-3 |
C9H15N3O2S |
|
Material intermediate |
162039-67-0 |
C18H14N4 |
|
(3-BROMOACETYL)COUMARIN |
29310-88-1 |
C11H7BrO3 |
|
Primary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
Sugammadex sodium Heptabromide intermediate |
|
|
|
Rabacfosadine succinate |
1431856-99-3 |
C25H41N8O10P |
|
Cefotiam (6R,7S) isomer reference |
|
|
|
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
|
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
|
t-boc-N-amido-PEG2-bromide |
164332-88-1 |
C9H18BrNO3 |
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
|
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
|
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
|
QUINUCLIDINE |
100-76-5 |
C7H13N |
|
6-nitrocoumarin |
2725-81-7 |
C9H5NO4 |
|
(S)-1-Amino-3-chloro-2-propanol hydrochloride |
34839-13-9 |
C3H9Cl2NO |
|
3,4-Dichloro-6-(trifluoromethyl)toluene |
74483-51-5 |
C8H5Cl2F3 |
|
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
|
4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole |
288071-87-4 |
C14H6Br2N2S3 |
|
(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
895152-66-6 |
C16H19NO |
|
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
|
20-HYDROXY PROSTAGLANDIN E2 |
57930-95-7 |
C20H32O6 |
|
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
|
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
|
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
C20H17BrN6O2 |
|
4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester |
123864-17-5 |
C38H42O10 |
|
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine |
314771-76-1 |
C18H16ClFN4O2 |
|
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
|
Cabazitaxel N-3 |
859498-31-0 |
C57H61Cl6NO19 |
|
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
|
Coumarin |
10172-75-5 |
C26H18O7 |
|
PROSTAGLANDIN H2 |
42935-17-1 |
C20H32O5 |
|
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
|
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
|
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
|
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
|
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
|
5-Fluoroindole |
399-52-0 |
C8H6FN |
|
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
|
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
|
Material intermediate |
75286-83-8 |
C52H38N4O8 |
|
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
|
Cefradine double nucleus |
|
|
|
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
|
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
|
CEFMETAZOLE MMT ISOMER |
|
|
|
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
|
NA |
|
|
|
Cefminox for system suitability |
|
|
|
Flomoxef Intermediate NaMT |
|
|
|
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
|
8-OXO-DG |
|
|